The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Genomics Personalized Health Market Research Report 2024

Global Genomics Personalized Health Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1892771

No of Pages : 83

Synopsis

The demand of Genomics Personalized Health is increasing owing to rise in the biopharmaceutical and healthcare industry. The other drivers for genomics personalized health the market are increase in prevalence of cancer, increase in geriatric population, increasing attentiveness towards health in emerging economies.

The global Genomics Personalized Health market was valued at US$ 9232.4 million in 2023 and is anticipated to reach US$ 16780 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.

North American market for Genomics Personalized Health is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Genomics Personalized Health is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Genomics Personalized Health in Academics & Research Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Genomics Personalized Health include QIAGEN, Illumina, Thermo Fisher Scientific, Bio-Rad, Roche, Lonza, INVITAE, Genetic Technologies and Interleukin Genetics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Genomics Personalized Health, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomics Personalized Health.

Report Scope

The Genomics Personalized Health market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genomics Personalized Health market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genomics Personalized Health companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • QIAGEN
  • Illumina
  • Thermo Fisher Scientific
  • Bio-Rad
  • Roche
  • Lonza
  • INVITAE
  • Genetic Technologies
  • Interleukin Genetics
  • Eastern Biotech
  • DNA Genotek
  • UBiome
  • XCode Life

Segment by Type

  • NGS Platforms
  • RT-PCR
  • Microarray
  • Genetic Analyzers

Segment by Application

  • Academics & Research Institutes
  • Diagnostic Centers

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomics Personalized Health companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics Personalized Health Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NGS Platforms
1.2.3 RT-PCR
1.2.4 Microarray
1.2.5 Genetic Analyzers
1.3 Market by Application
1.3.1 Global Genomics Personalized Health Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academics & Research Institutes
1.3.3 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomics Personalized Health Market Perspective (2019-2030)
2.2 Genomics Personalized Health Growth Trends by Region
2.2.1 Global Genomics Personalized Health Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genomics Personalized Health Historic Market Size by Region (2019-2024)
2.2.3 Genomics Personalized Health Forecasted Market Size by Region (2025-2030)
2.3 Genomics Personalized Health Market Dynamics
2.3.1 Genomics Personalized Health Industry Trends
2.3.2 Genomics Personalized Health Market Drivers
2.3.3 Genomics Personalized Health Market Challenges
2.3.4 Genomics Personalized Health Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomics Personalized Health Players by Revenue
3.1.1 Global Top Genomics Personalized Health Players by Revenue (2019-2024)
3.1.2 Global Genomics Personalized Health Revenue Market Share by Players (2019-2024)
3.2 Global Genomics Personalized Health Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomics Personalized Health Revenue
3.4 Global Genomics Personalized Health Market Concentration Ratio
3.4.1 Global Genomics Personalized Health Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics Personalized Health Revenue in 2023
3.5 Genomics Personalized Health Key Players Head office and Area Served
3.6 Key Players Genomics Personalized Health Product Solution and Service
3.7 Date of Enter into Genomics Personalized Health Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics Personalized Health Breakdown Data by Type
4.1 Global Genomics Personalized Health Historic Market Size by Type (2019-2024)
4.2 Global Genomics Personalized Health Forecasted Market Size by Type (2025-2030)
5 Genomics Personalized Health Breakdown Data by Application
5.1 Global Genomics Personalized Health Historic Market Size by Application (2019-2024)
5.2 Global Genomics Personalized Health Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Genomics Personalized Health Market Size (2019-2030)
6.2 North America Genomics Personalized Health Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Genomics Personalized Health Market Size by Country (2019-2024)
6.4 North America Genomics Personalized Health Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomics Personalized Health Market Size (2019-2030)
7.2 Europe Genomics Personalized Health Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Genomics Personalized Health Market Size by Country (2019-2024)
7.4 Europe Genomics Personalized Health Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomics Personalized Health Market Size (2019-2030)
8.2 Asia-Pacific Genomics Personalized Health Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Genomics Personalized Health Market Size by Region (2019-2024)
8.4 Asia-Pacific Genomics Personalized Health Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomics Personalized Health Market Size (2019-2030)
9.2 Latin America Genomics Personalized Health Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Genomics Personalized Health Market Size by Country (2019-2024)
9.4 Latin America Genomics Personalized Health Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomics Personalized Health Market Size (2019-2030)
10.2 Middle East & Africa Genomics Personalized Health Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Genomics Personalized Health Market Size by Country (2019-2024)
10.4 Middle East & Africa Genomics Personalized Health Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 QIAGEN
11.1.1 QIAGEN Company Detail
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN Genomics Personalized Health Introduction
11.1.4 QIAGEN Revenue in Genomics Personalized Health Business (2019-2024)
11.1.5 QIAGEN Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Genomics Personalized Health Introduction
11.2.4 Illumina Revenue in Genomics Personalized Health Business (2019-2024)
11.2.5 Illumina Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Genomics Personalized Health Introduction
11.3.4 Thermo Fisher Scientific Revenue in Genomics Personalized Health Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Bio-Rad
11.4.1 Bio-Rad Company Detail
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad Genomics Personalized Health Introduction
11.4.4 Bio-Rad Revenue in Genomics Personalized Health Business (2019-2024)
11.4.5 Bio-Rad Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Genomics Personalized Health Introduction
11.5.4 Roche Revenue in Genomics Personalized Health Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Lonza
11.6.1 Lonza Company Detail
11.6.2 Lonza Business Overview
11.6.3 Lonza Genomics Personalized Health Introduction
11.6.4 Lonza Revenue in Genomics Personalized Health Business (2019-2024)
11.6.5 Lonza Recent Development
11.7 INVITAE
11.7.1 INVITAE Company Detail
11.7.2 INVITAE Business Overview
11.7.3 INVITAE Genomics Personalized Health Introduction
11.7.4 INVITAE Revenue in Genomics Personalized Health Business (2019-2024)
11.7.5 INVITAE Recent Development
11.8 Genetic Technologies
11.8.1 Genetic Technologies Company Detail
11.8.2 Genetic Technologies Business Overview
11.8.3 Genetic Technologies Genomics Personalized Health Introduction
11.8.4 Genetic Technologies Revenue in Genomics Personalized Health Business (2019-2024)
11.8.5 Genetic Technologies Recent Development
11.9 Interleukin Genetics
11.9.1 Interleukin Genetics Company Detail
11.9.2 Interleukin Genetics Business Overview
11.9.3 Interleukin Genetics Genomics Personalized Health Introduction
11.9.4 Interleukin Genetics Revenue in Genomics Personalized Health Business (2019-2024)
11.9.5 Interleukin Genetics Recent Development
11.10 Eastern Biotech
11.10.1 Eastern Biotech Company Detail
11.10.2 Eastern Biotech Business Overview
11.10.3 Eastern Biotech Genomics Personalized Health Introduction
11.10.4 Eastern Biotech Revenue in Genomics Personalized Health Business (2019-2024)
11.10.5 Eastern Biotech Recent Development
11.11 DNA Genotek
11.11.1 DNA Genotek Company Detail
11.11.2 DNA Genotek Business Overview
11.11.3 DNA Genotek Genomics Personalized Health Introduction
11.11.4 DNA Genotek Revenue in Genomics Personalized Health Business (2019-2024)
11.11.5 DNA Genotek Recent Development
11.12 UBiome
11.12.1 UBiome Company Detail
11.12.2 UBiome Business Overview
11.12.3 UBiome Genomics Personalized Health Introduction
11.12.4 UBiome Revenue in Genomics Personalized Health Business (2019-2024)
11.12.5 UBiome Recent Development
11.13 XCode Life
11.13.1 XCode Life Company Detail
11.13.2 XCode Life Business Overview
11.13.3 XCode Life Genomics Personalized Health Introduction
11.13.4 XCode Life Revenue in Genomics Personalized Health Business (2019-2024)
11.13.5 XCode Life Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’